drugset / Trial / NCT02319603
To Evaluate the Efficacy and Safety of Wenxin Keli in Treating Atrial Premature Beats
RandomizedParallel-groupDouble-blindTreatment
Summary
A randomized, double-blind, two dose group, parallel-control multi-center, post-marketing clinical trial,to evaluate the efficacy and safety of Wenxin keli in treating atrial premature beats by different dose,to provide a scientific basis for rational clinical use of drug.
Timeline
- Start
- 2015-01
- Primary completion
- 2017-02
- Completion
- 2017-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | WenXin keli | Unknown | 5 g | Oral |
| Comparator | WenXin keli | Unknown | 10 g | Oral |